HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoko Tajima Selected Research

voglibose (Basen)

11/2013Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes.
12/2010Cost-effectiveness analysis of voglibose for prevention of type 2 diabetes mellitus in Japanese patients with impaired glucose tolerance.
9/2009[Alpha-glucosidase inhibitor for the prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese subjects with impaired glucose tolerance].
5/2009Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.
3/2005Suppression of body weight gain preserves acute insulin response to glucose in the portal vein of spontaneously type 2 diabetic rats with visceral obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoko Tajima Research Topics

Disease

37Type 2 Diabetes Mellitus (MODY)
04/2022 - 08/2002
15Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2004
14Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019 - 02/2002
10Hypertension (High Blood Pressure)
03/2020 - 07/2004
10Hypercholesterolemia
03/2016 - 01/2008
9Insulin Resistance
05/2020 - 01/2002
9Diabetes Mellitus
05/2020 - 01/2003
9Obesity
09/2017 - 03/2005
9Glucose Intolerance
08/2011 - 01/2005
8Hyperglycemia
06/2016 - 01/2005
7Diabetes Complications
04/2022 - 10/2004
5Abdominal Obesity
03/2014 - 01/2004
4Body Weight (Weight, Body)
01/2020 - 03/2005
4Neoplasms (Cancer)
03/2016 - 01/2008
4Cerebral Infarction
03/2015 - 01/2008
4Coronary Disease (Coronary Heart Disease)
05/2013 - 01/2008
4Atherosclerosis
05/2013 - 01/2005
4Hyperlipidemias (Hyperlipidemia)
02/2006 - 10/2004
3Albuminuria
03/2020 - 10/2007
3Hypoglycemia (Reactive Hypoglycemia)
08/2017 - 07/2010
3Diabetic Nephropathies (Diabetic Nephropathy)
12/2014 - 02/2002
3Stroke (Strokes)
09/2009 - 04/2007
3Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2009 - 04/2006
2Fibrosis (Cirrhosis)
12/2014 - 04/2008
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2014 - 09/2012
2Parkinson Disease (Parkinson's Disease)
09/2014 - 09/2012
2Overweight
09/2012 - 08/2011
2Dyslipidemias (Dyslipidemia)
02/2009 - 10/2007
2Hypertrophy
04/2008 - 12/2006
2Disease Progression
12/2007 - 05/2003
2Pediatric Obesity
12/2007 - 05/2007
2Heart Failure
04/2007 - 07/2004
2Hypertriglyceridemia
11/2005 - 12/2004
1Tooth Loss
01/2021
1Kidney Diseases (Kidney Disease)
12/2014

Drug/Important Bio-Agent (IBA)

31Glucose (Dextrose)FDA LinkGeneric
05/2020 - 01/2002
18Insulin (Novolin)FDA Link
01/2020 - 01/2002
9Pravastatin (Pravachol)FDA LinkGeneric
03/2015 - 01/2008
7HDL CholesterolIBA
01/2019 - 02/2006
7AdiponectinIBA
03/2014 - 12/2004
6Hypoglycemic Agents (Hypoglycemics)IBA
01/2019 - 05/2003
6LipidsIBA
01/2019 - 12/2007
5Sitagliptin Phosphate (Januvia)FDA Link
05/2020 - 10/2011
5Blood Glucose (Blood Sugar)IBA
08/2017 - 10/2007
5Triglycerides (Triacylglycerol)IBA
03/2015 - 12/2004
5voglibose (Basen)IBA
11/2013 - 03/2005
4Hemoglobins (Hemoglobin)IBA
05/2020 - 03/2006
4Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
03/2020 - 09/2007
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019 - 01/2008
4Glycoside Hydrolase InhibitorsIBA
09/2009 - 02/2005
4Adrenocorticotropic Hormone (ACTH)FDA Link
01/2009 - 05/2003
4Angiotensin Receptor AntagonistsIBA
04/2007 - 07/2004
3Metformin (Glucophage)FDA LinkGeneric
08/2017 - 10/2008
3Pharmaceutical PreparationsIBA
08/2017 - 12/2004
3oxidized low density lipoproteinIBA
03/2016 - 09/2009
3rho-Associated KinasesIBA
12/2014 - 07/2007
3Pioglitazone (Actos)FDA Link
10/2011 - 02/2006
3AcarboseFDA LinkGeneric
03/2011 - 01/2005
3AlbuminsIBA
01/2009 - 03/2006
3PPAR gammaIBA
01/2007 - 01/2002
2Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
10/2017 - 03/2009
2LDL CholesterolIBA
05/2013 - 09/2009
2GlucosidasesIBA
03/2011 - 03/2011
2miglitol (Glyset)FDA Link
03/2011 - 03/2011
2AdipokinesIBA
06/2009 - 12/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2009 - 12/2007
2LeptinIBA
12/2007 - 05/2007
2Biomarkers (Surrogate Marker)IBA
12/2007 - 04/2006
2fasudil (AT 877)IBA
11/2007 - 07/2007
2CreatinineIBA
10/2007 - 12/2005
2CalciumIBA
09/2007 - 07/2004
2Valsartan (Vals)FDA Link
04/2007 - 07/2004
2Glyburide (Glibenclamide)FDA LinkGeneric
02/2006 - 01/2005
2Nateglinide (Starlix)FDA LinkGeneric
12/2004 - 11/2003
2BezafibrateIBA
12/2004 - 01/2004
2Messenger RNA (mRNA)IBA
12/2004 - 01/2004
1CarbohydratesIBA
04/2022
1empagliflozinIBA
01/2020
1Antihypertensive Agents (Antihypertensives)IBA
01/2019
1Fibric Acids (Fibrates)IBA
01/2019
1Protein Kinase CIBA
10/2017
1SecretagoguesIBA
06/2016
1Short-Acting InsulinIBA
06/2016
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
12/2014
1TocotrienolsIBA
09/2014
1AntioxidantsIBA
09/2014
1Estrogen ReceptorsIBA
09/2014
1Vitamin EFDA LinkGeneric
09/2014
1Protein Isoforms (Isoforms)IBA
03/2014
1Dietary FiberFDA Link
07/2013
1ORALIT (ORS)IBA
09/2012
1Chlorogenic AcidIBA
09/2012
1SynucleinsIBA
09/2012
1PolyphenolsIBA
09/2012

Therapy/Procedure

15Glycemic Control
01/2021 - 12/2004
15Therapeutics
03/2017 - 01/2003
3Exercise Therapy (Therapy, Exercise)
04/2022 - 07/2013
2Renal Replacement Therapy (Therapies, Renal Replacement)
09/2007 - 07/2003
1Nutrition Therapy (Medical Nutrition Therapy)
04/2022
1Secondary Prevention
01/2022